Benchtop evaluation and animal studies for a new biodegradable neurovascular device were set to begin in just a few weeks. There was just one problem, though: the device prototype had yet to be completed. The original development partner was facing resource constraints and could no longer meet the client’s needs.
At this stage, the device developer could not adhere to the standard three- to five-week lead time typically required for one round of prototyping. The pressure was on—missing the animal study deadline would seriously jeopardize the project.